Hepatic Encephalopathy Global Clinical Trials Review, H1, 2015
Summary
GlobalData's clinical trial report, “Hepatic Encephalopathy Global Clinical Trials Review, H1, 2015" provides data on the Hepatic Encephalopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatic Encephalopathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatic Encephalopathy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hepatic Encephalopathy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hepatic Encephalopathy to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hepatic Encephalopathy to Gastrointestinal Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Hepatic Encephalopathy 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Hepatic Encephalopathy Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Salix Pharmaceuticals Ltd. 32
Clinical Trial Overview of Salix Pharmaceuticals Ltd. 32
Hyperion Therapeutics, Inc. 33
Clinical Trial Overview of Hyperion Therapeutics, Inc. 33
Ocera Therapeutics, Inc. 34
Clinical Trial Overview of Ocera Therapeutics, Inc. 34
CD Pharma India Private Ltd. 35
Clinical Trial Overview of CD Pharma India Private Ltd. 35
ASKA Pharmaceutical Co., Ltd. 36
Clinical Trial Overview of ASKA Pharmaceutical Co., Ltd. 36
Win Medicare Pvt. Ltd. 37
Clinical Trial Overview of Win Medicare Pvt. Ltd. 37
Ono Pharmaceutical Co., Ltd. 38
Clinical Trial Overview of Ono Pharmaceutical Co., Ltd. 38
Clinical Trial Overview of Top Institutes / Government 39
Govind Ballabh Pant Hospital 39
Clinical Trial Overview of Govind Ballabh Pant Hospital 39
New York University School of Medicine 40
Clinical Trial Overview of New York University School of Medicine 40
Dayanand Medical College & Hospital 41
Clinical Trial Overview of Dayanand Medical College & Hospital 41
University of Catania 42
Clinical Trial Overview of University of Catania 42
The Hunter Holmes McGuire VA Medical Center 43
Clinical Trial Overview of The Hunter Holmes McGuire VA Medical Center 43
Weill Cornell Medical College 44
Clinical Trial Overview of Weill Cornell Medical College 44
Postgraduate Institute of Medical Education and Research 45
Clinical Trial Overview of Postgraduate Institute of Medical Education and Research 45
Aga Khan University 46
Clinical Trial Overview of Aga Khan University 46
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 47
Clinical Trial Overview of Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 47
Institut Recerca Hospital Universitari Vall d'Hebron 48
Clinical Trial Overview of Institut Recerca Hospital Universitari Vall d'Hebron 48
Five Key Clinical Profiles 49
Appendix 68
Abbreviations 68
Definitions 68
Research Methodology 69
Secondary Research 69
About GlobalData 70
Contact Us 70
Disclaimer 70
Source 70
List Of Tables
List of Tables
Hepatic Encephalopathy Therapeutics, Global, Clinical Trials by Region, 2015* 7
Hepatic Encephalopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Hepatic Encephalopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Hepatic Encephalopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Hepatic Encephalopathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Hepatic Encephalopathy Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Hepatic Encephalopathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Hepatic Encephalopathy Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Hepatic Encephalopathy to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Hepatic Encephalopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Hepatic Encephalopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Hepatic Encephalopathy to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Hepatic Encephalopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Hepatic Encephalopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Hepatic Encephalopathy Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Hepatic Encephalopathy Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Hepatic Encephalopathy Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Hepatic Encephalopathy Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Hepatic Encephalopathy Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Hepatic Encephalopathy Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Hepatic Encephalopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Hepatic Encephalopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Hepatic Encephalopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Hepatic Encephalopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Hepatic Encephalopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
Hepatic Encephalopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Salix Pharmaceuticals Ltd., 2015* 32
Hepatic Encephalopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Hyperion Therapeutics, Inc., 2015* 33
Hepatic Encephalopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Ocera Therapeutics, Inc., 2015* 34
Hepatic Encephalopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by CD Pharma India Private Ltd., 2015* 35
Hepatic Encephalopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by ASKA Pharmaceutical Co., Ltd., 2015* 36
Hepatic Encephalopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Win Medicare Pvt. Ltd., 2015* 37
Hepatic Encephalopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Ono Pharmaceutical Co., Ltd., 2015* 38
Hepatic Encephalopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Govind Ballabh Pant Hospital, 2015* 39
Hepatic Encephalopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2015* 40
Hepatic Encephalopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Dayanand Medical College & Hospital, 2015* 41
Hepatic Encephalopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Catania, 2015* 42
Hepatic Encephalopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by The Hunter Holmes McGuire VA Medical Center, 2015* 43
Hepatic Encephalopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2015* 44
Hepatic Encephalopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Postgraduate Institute of Medical Education and Research, 2015* 45
Hepatic Encephalopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Aga Khan University, 2015* 46
Hepatic Encephalopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, 2015* 47
Hepatic Encephalopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut Recerca Hospital Universitari Vall d'Hebron, 2015* 48
List Of Figures
List of Figures
Hepatic Encephalopathy Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Hepatic Encephalopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Hepatic Encephalopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Hepatic Encephalopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Hepatic Encephalopathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Hepatic Encephalopathy Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Hepatic Encephalopathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Hepatic Encephalopathy to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Hepatic Encephalopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Hepatic Encephalopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Hepatic Encephalopathy to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Hepatic Encephalopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Hepatic Encephalopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Hepatic Encephalopathy Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Hepatic Encephalopathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Hepatic Encephalopathy Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Hepatic Encephalopathy Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Hepatic Encephalopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Hepatic Encephalopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Hepatic Encephalopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Hepatic Encephalopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Hepatic Encephalopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
GlobalData Methodology 69
